CryoPort
CYRX
14 hedge funds and large institutions have $497K invested in CryoPort in 2016 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.
400% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 1
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
89% more capital invested
Capital invested by funds: $263K → $497K (+$234K)
40% more funds holding
Funds holding: 10 → 14 (+4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$77.8K |
| 2 |
Stifel Financial
St. Louis,
Missouri
|
+$69.7K |
| 3 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$44.2K |
| 4 |
Morgan Stanley
New York
|
+$20K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$11.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4.86K |
| 2 |
Walleye Trading
New York
|
-$2K |
CYRX Hedge Fund Activity: Q2 2016 in Review
14 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in CryoPort (CYRX) for Q2 2016, worth a combined $497K — up 89% from $263K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new CYRX positions and 1 closed out — a net gain of 4 holders — while 3 added to existing stakes and 1 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $77.8K. The largest seller was Tower Research Capital (TRC), cutting an estimated $4.86K.
- 14 institutional investors held CryoPort (CYRX) as of Q2 2016, up from 10 in Q1 2016.
- Funds reported $497K of CryoPort stock for Q2 2016, up 89% quarter-over-quarter.
- 5 funds opened new CryoPort positions in Q2 2016 and 1 closed out, a net change of +4 holders.
- The largest CryoPort buyer in Q2 2016 was Millennium Management, an estimated $77.8K added.
- The largest CryoPort seller in Q2 2016 was Tower Research Capital (TRC), an estimated $4.86K sold.
Based on aggregated 13F filings for Q2 2016.